Trial in Progress: A Phase 3, Randomized, Double-Blind Study of Midostaurin in Combination with Chemotherapy and as Single-Agent Maintenance Therapy in Newly Diagnosed Patients with FLT3 Mutation–Negative Acute Myeloid Leukemia (AML)
| Autor: | Bourras-Rezki Bengoudifa, Noah Berkowitz, Richard Stone, Jorge Sierra, Albert Hoenekopp, Gert J. Ossenkoppele, Hartmut Döhner, Carolin Sachs |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Myeloid leukemia Hematology Newly diagnosed Double blind study 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Maintenance therapy chemistry 030220 oncology & carcinogenesis Internal medicine Flt3 mutation medicine Single agent Midostaurin business |
| Zdroj: | Clinical Lymphoma Myeloma and Leukemia. 18:S206-S207 |
| ISSN: | 2152-2650 |
| DOI: | 10.1016/j.clml.2018.07.060 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect